课题基金 / 基金详情

BONE TURNOVER IN SICKLE CELL DISEASE

BONE TURNOVER IN SICKLE CELL DISEASE
镰状细胞病中的骨转换
批准号:
7605010
负责人:
John David Roberts
金额:
$0.56万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-20 至 2007-11-30

项目摘要

项目成果

John David Roberts的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. It is proposed that an increase in bone turnover may play a role in bone pain and developmemt of sickle cell crisis. Therefore this protocol will measure bone metabolism via quantification of serum bone specific alkaline phosphatase and N-telopeptide. The aim is to investigate whether increased bone turnover is temporally related to sickle cell crisis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
  • 批准号:
    8166535
  • 项目类别:
  • 资助金额:
    $2.24万
  • 财政年份:
    2009
  • 负责人:
    John David Roberts
  • 依托单位:
CLINICAL TRIAL: PILOT/PHASE 1 STUDY OF ZOLEDRONIC ACID (ZOMETA ) IN SICKLE CELL
  • 批准号:
    7950882
  • 项目类别:
  • 资助金额:
    $0.09万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
Clinical Protocol and Data Management
  • 批准号:
    7698841
  • 项目类别:
  • 资助金额:
    $2.1万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
  • 批准号:
    7950860
  • 项目类别:
  • 资助金额:
    $3.22万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
海外基金